Some exciting news in the war on cancer. A new study shows an experimental drug that taps into the power of the body's immune system to fight cancer, is shrinking tumors in patients for whom other treatments had failed.
The drug binds to a protein called PD-L1 that sits on the surface of cancer cells and makes them invisible to the immune system, almost like a cloaking device.
That protein allows the tumor cell to grow unchecked and cause harm to the patient. But with the protein blocked, the immune system can see and destroy cancer cells.
21% of patients initially saw significant tumor shrinkage after at least three months on the medication. One patient saw tumors disappear completely.
The drug also seems to work on a wide range of cancers including those toughest to treat. They include non small cell lung cancer, melanoma, colo-rectal, kidney and stomach cancer.
One researcher says this has all the characteristics of a really amazing drug. He says he can count on one hand the number of times he's seen response rates like this.
At least five companies are involved in backing this research and on scientist says he doesn't think in the history of cancer therapy we've had five or more companies working to develop antibodies targeted at the same pathway.







